MNC-168 Enteric-coated Capsule

MNC-168 · Moon (Guangzhou) Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MNC-168 Enteric-coated Capsule, covering 2025-07-02 to 2025-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of MNC-168 Enteric-coated Capsule in the Treatment of Advanced Intestinal Solid Tumor [Phase 1]